Benjamin Ruf
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Immunology 14
- Immune Cell Function and Interaction 11
- T-cell and B-cell Immunology 3
- IL-33, ST2, and ILC Pathways 3
- Oncology 9
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Co-authors
- Tim F. Greten (20 shared papers)Bernd Heinrich (9 shared papers)Firouzeh Korangy (9 shared papers)Xin Wei Wang (3 shared papers)Chi Ma (12 shared papers)Simon Wabitsch (10 shared papers)Laurence P. Diggs (6 shared papers)John C. McVey (7 shared papers)
- Journals
- Molecular Therapy — Oncolytics (2 papers)iScience (2 papers)Cancer Immunology Research (2 papers)Mycoses (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesGermanyUkraine
In The Last Decade
Benjamin Ruf
29 papers receiving 949 citations
Benjamin Ruf's Hit Papers
Peers
Comparison fields: 5 of 75
- Hepatology 118
- Immunology 269
- Oncology 281
- Cancer Research 114
- Epidemiology 161
Countries citing papers authored by Benjamin Ruf
This map shows the geographic impact of Benjamin Ruf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Ruf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Ruf more than expected).
Fields of papers citing papers by Benjamin Ruf
This network shows the impact of papers produced by Benjamin Ruf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Ruf. The network helps show where Benjamin Ruf may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Ruf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 226 | |
| 2 | Biomarkers for immunotherapy of hepatocellular carcinoma Hit paper breakdown → | 2023 | 122 |
| 3 | 2022 | 111 | |
| 4 | 2023 | 79 | |
| 5 | 2020 | 60 | |
| 6 | 2023 | 52 | |
| 7 | 2021 | 41 | |
| 8 | 2016 | 34 | |
| 9 | 2019 | 28 | |
| 10 | 2015 | 26 | |
| 11 | 2021 | 25 | |
| 12 | 2022 | 19 | |
| 13 | 1996 | 17 | |
| 14 | 2020 | 17 | |
| 15 | 2024 | 16 | |
| 16 | 2023 | 13 | |
| 17 | 2015 | 12 | |
| 18 | 2023 | 9 | |
| 19 | 2023 | 9 | |
| 20 | 2022 | 8 |
About Benjamin Ruf
Benjamin Ruf is a scholar working on Immunology, Oncology, Molecular Biology, Surgery and Epidemiology, having authored 30 papers that have together received 950 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (4 papers), T-cell and B-cell Immunology (3 papers), IL-33, ST2, and ILC Pathways (3 papers), CAR-T cell therapy research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Adenosine and Purinergic Signaling (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (118 citations), Immunology (269 citations), Oncology (281 citations), Cancer Research (114 citations) and Epidemiology (161 citations). Benjamin Ruf has collaborated with scholars based in United States, Germany and Ukraine. Frequent co-authors include Tim F. Greten, Bernd Heinrich, Firouzeh Korangy, Xin Wei Wang, Chi Ma, Simon Wabitsch, Laurence P. Diggs, John C. McVey, Lichun Ma and Mark Yarchoan. Their work appears in journals such as Molecular Therapy — Oncolytics, iScience, Cancer Immunology Research, Mycoses and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.